Doripenem - A New Broad-Spectrum Carabapenem Antibiotic

 

Key Data:

Drug (Brand/Generic)
Doripenem
Company/Licensee
Shionogi/J&J
Therapy Class
ß-lactam (carbapenem)
Product Description
Antibiotic
Current Indication
Treatment of serious bacterial infections
Market Sector
Anti-infectives
Development Status
Approved in the US, Japan and Europe



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development